Related Experiment Video
Updated: Jun 4, 2026

10:46
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Methods for estimating remission rates from cross-sectional survey data: application and validation using data from a
1Center for Clinical Epidemiology and Biostatistics, School of Medicine, University of Pennsylvania, 423 Guardian Drive, Philadelphia, PA 19104, USA. jaroy@upenn.edu
American Journal of Epidemiology
|March 2, 2011
Summary
This study estimates migraine remission rates using national survey data and a novel Bayesian approach. Migraine remission increases with age and is similar for both men and women.
Area of Science:
- Neurology
- Epidemiology
- Biostatistics
Background:
- Chronic episodic disorders, such as migraine, have poorly understood remission rates.
- Medical records often fail to capture remission as patients may cease seeking care.
- Prospective studies are challenging due to issues like outcome-dependent dropout.
Purpose of the Study:
- To propose and validate an alternative method for estimating remission rates using cross-sectional survey data.
- To estimate migraine remission rates in the general population.
- To investigate the relationship between age, sex, and migraine remission.
Main Methods:
- Developed a Bayesian approach to model sex- and age-specific remission rates.
- Utilized cross-sectional data from a 2004 national survey, including reported age of onset.
- Validated the methodology using follow-up survey data from 2005.
Main Results:
- Migraine remission rates were found to increase with age.
- Remission rates were similar for both men and women.
- Estimated remission curves derived from cross-sectional data closely matched those from validation data.
Conclusions:
- The proposed Bayesian method effectively estimates migraine remission rates from cross-sectional data.
- Age is a significant factor in migraine remission.
- The findings provide valuable insights for understanding migraine chronicity and treatment.
